Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: A critical review of evidence

Current Opinion in Urology

Volumn 22, Issue 1, 2012, Pages 22-33

  Bachmann, Alexander ^a   Woo, Henry H ^b   Wyler, Stephen ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

940 nm; 980 nm; diode; electroresection of the prostate; evidence; greenlight; holmium enucleation of the prostate; HPS; KTP; laser prostatectomy; levels of evidence; oxford centre for evidence based medicine review; thulium; Tm:YAG; transurethral electro resection of the prostate, XPS

Indexed keywords

BLEEDING; CLINICAL EFFECTIVENESS; DIODE LASER; EVIDENCE BASED MEDICINE; FOLLOW UP; GREENLIGHT LASER PROSTATECTOMY; HOLMIUM LASER PORSTATECTOMY; HUMAN; LASER PROSTATECTOMY; LOWER URINARY TRACT SYMPTOM; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SURGICAL TECHNIQUE; THULIUM LASER PROSTATECTOMY; TRANSURETHRAL ELECTROVAPORIZATION;

EVIDENCE-BASED MEDICINE; HUMANS; LASER THERAPY; LASERS, SEMICONDUCTOR; LASERS, SOLID-STATE; LOWER URINARY TRACT SYMPTOMS; MALE; PROSTATIC HYPERPLASIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 83055178124     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32834dd0ed     Document Type: Review

References (81)

1. Freyer PJ. One thousand cases of total enucleation of the prostate for radical cure of enlargement of that organ. Br Med J 1920; 2:868-870.
2. Wendt-Nordahl G, Hacker A, Fastenmeier K, et al. New bipolar resection device for transurethral resection of the prostate: first ex-vivo and in-vivo evaluation. J Endourol 2005; 19:1203-1209. (Pubitemid 43082916)
3. Hartung R, Leyh H, Liapi C, et al. Coagulating intermittent cutting. Improved high-frequency surgery in transurethral prostatectomy. Eur Urol 2001; 39:676-681. (Pubitemid 32679637)
4. Faul P, Schlenker B, Gratzke C, et al. Clinical and technical aspects of bipolar transurethral prostate resection. Scand J Urol Nephrol 2008; 42:318-323.
5. Reich O, Schlenker B, Gratzke C, et al. Plasma vaporisation of the prostate: initial clinical results. Eur Urol 2010; 57:693-697.
6. Reich O, Corvin S, Oberneder R, et al. In vitro comparison of transurethral vaporization of the prostate (tuvp), resection of the prostate (turp), and vaporization-resection of the prostate (tuvrp). Urol Res 2002; 30:15-20. (Pubitemid 36055938)
7. Rieken M, Ebinger Mundorff N, Bonkat G, et al. Complications of laser prostatectomy: a review of recent data. World J Urol 2010; 28:53-62.
8. Burke N, Whelan JP, Goeree L, et al. Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology 2010; 75:1015-1022.
9. Lourenco T, Pickard R, Vale L, et al. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ 2008; 337:a449.
10. Lourenco T, Armstrong N, N'Dow J, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess 2008; 12:iii, ix-x, 1-146, 169-515.
11. Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010; 58:384-397.
12. Tan A, Liao C, Mo Z, Cao Y. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg 2007; 94:1201-1208. (Pubitemid 47584767)
13. Hoffman RM, MacDonald R, Slaton JW, Wilt TJ. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol 2003; 169:210-215. (Pubitemid 35461590)
14. Oelke M, Bachmann A, Desazeaud A, et al. Guidelines on the treatment of nonneurogenic male luts 2011. http://wwwuroweborg/gls/pdf/12-Male- LUTSpdf. Updated guidelines on lower urinary tract symptoms.
15. Mojon-Azzi SM, Jiang X, Wagner U, Mojon DS. Journals: redundant publications are bad news. Nature 2003; 421:209-1209.
16. Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312:71-72.
17. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007; 334:349-351. (Pubitemid 46328045)
18. Guyatt GH.Medicine before and after EBM (6 questions to gordon h. Guyatt). Recenti Prog Med 2008; 99:404-405.
19. Howick J, Chalmers I, Glasziou P, Greenhalgh T, et al. Explanation of the 2011 Oxford Centre for Evidence-based Medicine (OCEBM) levels of evidence (background document). Oxford Centre for Evidence-Based Medicine. http://wwwcebmnet/indexaspx?o=5653. 2011.
20. Howick J, Chalmers I, Glasziou P, Greenhalgh T, et al. The 2011 Oxford CEBM levels of evidence (introductory document). Oxford Centre for Evidence-Based Medicine. http://wwwcebmnet/indexaspx?o=5653. 2011.
21. Calza L, Manfredi R, Marinacci G, et al. Role of gancyclovir and HAART administration in the treatment of a rare complication of hiv disease: cytomegalovirus-associated guillain-barre syndrome. J Chemother 2001; 13:575-577. (Pubitemid 33001123)
22. Halpern SD, Karlawish JHT, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA 2002; 288:358-362. (Pubitemid 34761615)
23. Das DK, Al-Ayadhy B, Ajrawi MT, et al. Cytodiagnosis of nipple discharge: a study of 602 samples from 484 cases. Diagn Cytopathol 2001; 25:25-37. (Pubitemid 32622638)
24. Gilling PJ, Cass CB, Malcolm A, et al. Holmium laser resection of the prostate versus neodymium:yttrium-aluminum-garnet visual laser ablation of the prostate: a randomized prospective comparison of two techniques for laser prostatectomy. Urology 1998; 51:573-577. (Pubitemid 28186209)
25. Gilling PJ, Kennett K, Das AK, et al. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 1998; 12:457-459. (Pubitemid 28542483)
26. Madersbacher S, Lackner J, Brossner C, et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23 123 cases. Eur Urol 2005; 47:499-504. (Pubitemid 40357897)
27. Aho TF, Gilling PJ, Kennett KM, et al. Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: a randomized trial. J Urol 2005; 174:210-214. (Pubitemid 40825717)
28. Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol 2008; 53:160-166.
29. Ahyai SA, Lehrich K, Kuntz RM. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial. Eur Urol 2007; 52:1456-1463.
30. Wilson LC,Gilling PJ, Williams A, et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006; 50:569-573. (Pubitemid 44189064)
31. Briganti A, Naspro R, Gallina A, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol 2006; 175:1817-1821.
32. Montorsi F, Naspro R, Salonia A, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004; 172:1926-1929. (Pubitemid 39363092)
33. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004; 172:1012-1016. (Pubitemid 39096451)
34. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month followup of a randomized trial. J Endourol 2004; 18:189-191. (Pubitemid 38490012)
35. Tan AH, Gilling PJ, Kennett KM, et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003; 170:1270-1274. (Pubitemid 37108129)
36. Kuntz RM, Lehrich K. Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm: a randomized prospective trial of 120 patients. J Urol 2002; 168:1465-1469. (Pubitemid 35034148)
37. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004; 172:1012-1016. (Pubitemid 39096451)
38. Montorsi F, Naspro R, Salonia A, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2008; 179:S87-S90. (Pubitemid 351492528)
39. Rigatti L, Naspro R, Salonia A, et al. Urodynamics after turp and holep in urodynamically obstructed patients: are there any differences at 1 year of follow-up? Urology 2006; 67:1193-1198. (Pubitemid 43818084)
40. Gilling PJ, Aho TF, Frampton CM, et al. Holmium laser enucleation of the prostate: results at 6 years. Eur Urol 2008; 53:744-749. (Pubitemid 351273870)
41. Gilling PJ, Mackey M, Cresswell M, et al. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol 1999; 162:1640-1644. (Pubitemid 29474680)
42. Gilling PJ, Wilson LC, King CJ, et al. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int 2011.
43. Westenberg A, Gilling P, Kennett K, et al. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004; 172:616-619. (Pubitemid 38900219)
44. Gupta N, Sivaramakrishna, Kumar R, et al. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of ≥ 40 g. BJU Int 2006; 97:85-89.
45. Mavuduru RM, Mandal AK, Singh SK, et al. Comparison of holep and turp in terms of efficacy in the early postoperative period and perioperative morbidity. Urol Int 2009; 82:130-135.
46. Zhang Y, Du C-J, Xu G, et al. Transurethral holmium laser enucleation for prostate adenoma greater than 100 g [in Chinese]. Zhonghua Nan Ke Xue 2007; 13:1091-1093.
47. Kuntz RM, Lehrich K, Ahyai S. Transurethral holmium laser enucleation of the prostate compared with transvesical open prostatectomy: 18-month followup of a randomized trial. J Endourol 2004; 18:189-191. (Pubitemid 38490012)
48. Tan AHH, Gilling PJ, Kennett KM, et al. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003; 170:1270-1274. (Pubitemid 37108129)
49. Vavassori I, Hurle R, Vismara A, et al. Holmium laser enucleation of the prostate combined with mechanical morcellation: two years of experience with 196 patients. J Endourol 2004; 18:109-112. (Pubitemid 38295674)
50. Kuo RL, Paterson RF, Siqueira TM Jr, et al. Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology 2003; 62:59-63. (Pubitemid 36802072)
51. Bouchier-Hayes DM, Van Appledorn S, Bugeja P, et al. A randomized trial of photoselective vaporization of the prostate using the 80-w potassium-titanylphosphate laser vs transurethral prostatectomy, with a 1-year follow-up. BJU Int 2010; 105:964-969.
52. Bouchier-Hayes DM, Anderson P, Van Appledorn S, et al. Ktp laser versus transurethral resection: early results of a randomized trial. J Endourol 2006; 20:580-585. (Pubitemid 44689646)
53. Rieken M, Kang HW, Koullick E, et al. Laser vaporization of the prostate in vivo: experience with the 150-w 980-nm diode laser in living canines. Lasers Surg Med 2010; 42:736-742.
54. Alivizatos G, Skolarikos A, Chalikopoulos D, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas ≥80 ml: 12-mo results of a randomized prospective study. Eur Urol 2008; 54:427-437.
55. Horasanli K, Silay MS, Altay B, et al. Photoselective potassium titanyl phosphate (ktp) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 ml: a short-term prospective randomized trial. Urology 2008; 71:247-251. (Pubitemid 351282348)
56. Al-Ansari A, Younes N, Sampige VP, et al. Greenlight hps 120-w laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm followup. Eur Urol 2010; 58:349-355.
57. Capitan C, Blazquez C, Martin MD, et al. Greenlight hps 120-w laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol 2011; 60:734-739.
58. Skolarikos A, Papachristou C, Athanasiadis G, et al. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol 2008; 22:2333-2340.
59. Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (pvp) in patients on ongoing oral anticoagulation. Eur Urol 2007; 51:1031-1038; discussion 1038-1041.
60. Bachmann A, Schurch L, Ruszat R, et al. Photoselective vaporization (pvp) versus transurethral resection of the prostate (turp): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 2005; 48:965-971; discussion 972.
61. Ruszat R, Wyler SF, Seitz M, et al. Comparison of potassium-titanyl- phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective nonrandomized two-centre study. BJU Int 2008; 102:1432-1438; discussion 1438-1439.
62. Hai MA. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. Urology 2009; 73:807-810.
63. Te AE, Malloy TR, Stein BS, et al. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 2006; 97:1229-1233. (Pubitemid 43907328)
64. Fu WJ, Hong BF, Wang XX, et al. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl 2006; 8:367-371.
65. Te AE, Malloy TR, Stein BS, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first united states multicenter prospective trial. J Urol 2004; 172:1404-1408. (Pubitemid 39249730)
66. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80w ktp laser for the treatment of benign prostatic hyperplasia. J Endourol 2003; 17:93-96. (Pubitemid 36348884)
67. Ruszat R, Seitz M, Wyler SF, et al. Greenlight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. Eur Urol 2008; 54:893-901.
68. Bachmann A, Ruszat R. The ktp-(greenlight-) laser: principles and experiences. Minim Invasive Ther Allied Technol 2007; 16:5-10.
69. Bachmann A, Ruszat R, Wyler S, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol 2005; 47:798-804. (Pubitemid 40745349)
70. Sulser T, Reich O, Wyler S, et al. Photoselective ktp laser vaporization of the prostate: first experiences with 65 procedures. J Endourol 2004; 18:976-981. (Pubitemid 40070908)
71. Bachmann A, Reich O, Wyler S, et al. The 80w potassium-titanium-phosphate (ktp) laser vaporization of the prostate. Technique and 6 month followup after 70 procedures. Urologe A 2004; 43:1262-1270.
72. Fried NM. MKE: high-power thulium fiber laser ablation of urinary tissues at 1.94 micrometers. J Endourol 2005; 19:25-31. (Pubitemid 40365739)
73. Bach T, Herrmann T, Ganzer R, Burchardt M, et al. Revolix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 2007; 25:257-262.
74. Xia SJ, Zhuo J, Sun XW, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008; 53:382-389.
75. Bach T, Netsch C, Haecker A, et al. Thulium:Yag laser enucleation (vapoenucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 2010; 28:39-43.
76. Szlauer R, Gotschl R, Razmaria A, et al. Endoscopic vaporesection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique. Eur Urol 2009; 55:368-375.
77. Chiang PH, Chen CH, Kang CH, Chuang YC. Greenlight hps laser 120-w versus diode laser 200-w vaporization of the prostate: comparative clinical experience. Lasers Surg Med 2010; 42:624-629.
78. Ruszat R, Seitz M, Wyler SF, et al. Prospective single-centre comparison of 120-w diode-pumped solid-state high-intensity system laser vaporization of the prostate and 200-w high-intensive diode-laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int 2009; 104:820-825.
79. Seitz M, Bayer T, Ruszat R, et al. Preliminary evaluation of a novel side-fire diode laser emitting light at 940 nm, for the potential treatment of benign prostatic hyperplasia: ex-vivo and in-vivo investigations. BJU Int 2009; 103:770-775.
80. Biester K, Skipka G, Jahn R, et al. Systematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (noninferiority). BJU Int 2011. [Epub ahead of print].
81. ShingletonWB, Renfroe LD, Kolski JM, Fowler JE Jr. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol 1998; 32:266-269. (Pubitemid 28387177)